A proposal of an echocardiography-based pathway for the diagnosis and management of angina with no obstructive coronary arteries: a state-of-the-art review: Advancing Targeted Therapy and Prognosis Through Endotype Identification

Eur Heart J Imaging Methods Pract. 2026 Jul 22;4(3):qyag129. doi: 10.1093/ehjimp/qyag129. eCollection 2026 Aug.ABSTRACTIn this paper we are discussing the currently available tools in the diagnosis of angina with non-occlusive coronary artery disease (ANOCA) a potentially disabling condition that af

A Attila Kardos

Improving medication adherence in cardiovascular disease

Br J Cardiol. 2026 Apr 1;33(2):016. doi: 10.5837/bjc.2026.016. eCollection 2026.ABSTRACTThe management and prevention of cardiovascular diseases (CVD) is based on adequate adherence to medications and lifestyle changes. The reported rates of adherence with cardiovascular medications range from 30% t

H Hassan Al-Riyami

Real-world efficacy of inclisiran: data from a tertiary lipid clinic

Br J Cardiol. 2026 Apr 1;33(2):015. doi: 10.5837/bjc.2026.015. eCollection 2026.ABSTRACTSmall-interfering RNA (siRNA)-based therapies, such as inclisiran, offer a novel approach to reducing low-density lipoprotein-cholesterol (LDL-C) and preventing cardiovascular disease (CVD). Inclisiran inhibits p

M Matthew M A Waite